ClinicalTrials.Veeva

Menu

Genetic Contributions to Autism Spectrum Disorders

Boston Children's Hospital logo

Boston Children's Hospital

Status

Active, not recruiting

Conditions

Asperger's Syndrome
Pervasive Developmental Disorder
Autism Spectrum Disorder
Autism

Study type

Observational

Funder types

Other

Identifiers

NCT01160783
07-04-0136

Details and patient eligibility

About

This study is working towards gaining a better understanding of the genetic and environmental factors involved in autism spectrum disorders (ASD), which includes autism, pervasive developmental disorder (PDD), and Asperger's syndrome. The investigators hope that information gained from this study will lead to new ways of diagnosing and treating ASDs.

Full description

Participation generally takes less than 2 hours to complete and travel to Children's Hospital Boston is not required. Participants are asked some questions about their medical and family history. The investigators also request permission to review medical records related to the ASD diagnosis. Finally, the investigators obtain a small blood or saliva sample in order to search for genes that may be important in understanding ASD. The investigators can arrange for the blood draw through a participant's physician or a clinical laboratory and saliva samples can be obtained through the mail. The study questions are answered via telephone or mailed questionnaires. There is no cost to participate.

Enrollment

240 patients

Sex

All

Ages

18+ months old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Clinical diagnosis of an Autism Spectrum Disorder (autism, pervasive developmental disorder (PDD), or Asperger's syndrome)
  • Age > 18 months

Exclusion criteria

  • Do not have the diagnosis of an ASD
  • Participation in the "Phenotypic and Genetic Risk Factors in ASD" study at Boston Children's Hospital.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems